Tiptree Books $372 Million Gain as Fortegra Sale Closes
Tiptree's second-quarter diluted EPS jumped to $10.30 from $0.39 a year earlier after the company completed the $1.65 billion sale of Fortegra and unveiled a $100 million deal to buy specialty insurer Universal Shield.
Tiptree (TIPT) closed the $1.65 billion sale of Fortegra on May 29, 2026, collecting $1.12 billion in gross proceeds and booking a $372.2 million after-tax gain, a transaction first agreed in September 2025 that the company had guided toward a "mid-2026" close in prior releases. The holding company also closed the sale of Reliance First Capital on May 1 for $49.7 million cash, slightly below the $50 million estimate cited in the two preceding quarters.
The divestitures reshaped Tiptree's balance sheet within a single quarter. Total assets fell to $1.13 billion as of June 30 from $6.84 billion at year-end 2025, and total liabilities dropped to $227.0 million from $6.09 billion, as $6.77 billion in assets and $5.91 billion in liabilities held for sale were deconsolidated upon closing. Cash and cash equivalents rose to $946.9 million from $30.8 million over the same period, and the $243.8 million of non-controlling interests tied to Fortegra's preferred and common holders was eliminated entirely.
Book value per share climbed to $24.34 at June 30 from $13.42 at March 31 and $13.45 at December 31, 2025, running slightly ahead of the $23.80 pro-forma figure management had cited in the first quarter. Diluted EPS reached $10.30 for the quarter and $10.64 for the six months, up from $0.39 and $0.55 a year earlier, driven by the one-time gain on the sales rather than by recurring operating performance. Net income from discontinued operations totaled $395.7 million for the quarter and $417.1 million for the half, compared with $29.4 million and $44.7 million in the prior-year periods.
Stripped of Fortegra and Reliance, what remains of Tiptree's continuing operations now generates essentially no revenue: $0 in the second quarter versus $92 thousand a year earlier, and $0 for the six months versus $482 thousand, extending a decline that had already reached $3 thousand in the fourth quarter of 2025. Continuing-operations expenses fell alongside that shrinkage, to $9.1 million in the quarter from $12.0 million a year earlier and to $18.0 million from $24.9 million for the six months, as the holding company pared corporate overhead following the sale of its operating segments. The continuing-operations net loss narrowed to $6.4 million in the quarter from $10.4 million and to $13.6 million from $20.1 million for the six months.
Tiptree signaled where the Fortegra proceeds are headed. On July 29, the company announced a definitive agreement to acquire Universal Shield Insurance Group, a specialty property-and-casualty insurer, for $100 million cash, with the deal expected to close in the first quarter of 2027 — the first reinvestment target disclosed since the divestitures were agreed.
Tiptree also stepped up share repurchases, buying back $10.3 million of stock in the first half at an average price of $16.80 a share, following a new $20 million buyback program authorized alongside the Fortegra closing; $5.0 million of that total was repurchased in the first quarter at an average $16.13 a share. The quarterly dividend held at $0.06 a share through the period, though full-year 2025 dividends paid per share fell to $0.24 from $0.49 in 2024, a figure the company stopped disclosing in later releases as its capital-return focus shifted toward buybacks.